We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$8.93B
AUM Growth
-$427M
Cap. Flow
-$6.66M
Cap. Flow %
-0.07%
Top 10 Hldgs %
46.19%
Holding
665
New
38
Increased
95
Reduced
216
Closed
58

Top Buys

Rank Stock Value
1
VLTO icon
Veralto
VLTO
+$53.6M
2
PAYC icon
Paycom
PAYC
+$43.1M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$21.4M
4
FDS icon
Factset
FDS
+$15.8M
5
VEEV icon
Veeva Systems
VEEV
+$13.5M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$33.8M
2
IQV icon
IQVIA
IQV
+$17.1M
3
MA icon
Mastercard
MA
+$13M
4
DIS icon
Walt Disney
DIS
+$10.7M
5
PYPL icon
PayPal
PYPL
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 38.33%
2 Healthcare 16.32%
3 Consumer Discretionary 10.8%
4 Financials 10.77%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GME icon
601
GameStop
GME
$8.29B
$164 ﹤0.01%
12
XRX icon
602
Xerox
XRX
$416M
$162 ﹤0.01%
12
-341
-97% -$5.39K
MMYT icon
603
MakeMyTrip
MMYT
$5.66B
$155 ﹤0.01%
4
FBRX icon
604
Forte Biosciences
FBRX
$1.57B
$92 ﹤0.01%
8
BHF icon
605
Brighthouse Financial
BHF
$3.44B
$47 ﹤0.01%
1
-6
-86% -$298
RIGL icon
606
Rigel Pharmaceuticals
RIGL
$766M
$22 ﹤0.01%
3
FTCH
607
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$3 ﹤0.01%
2
ACB
608
Aurora Cannabis
ACB
$240M
-2
Closed -$11
ACWX icon
609
iShares MSCI ACWI ex US ETF
ACWX
$12B
-707
Closed -$34.8K
ADM icon
610
Archer Daniels Midland
ADM
$38.5B
-1,768
Closed -$134K
AEG icon
611
Aegon
AEG
$13.9B
-2,380
Closed -$12.1K
ANGL icon
612
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.12B
-482
Closed -$13.4K
ARCB icon
613
ArcBest
ARCB
$3.23B
-100
Closed -$9.88K
BALL icon
614
Ball Corp
BALL
$16.5B
-2,536
Closed -$148K
CNDT icon
615
Conduent
CNDT
$240M
-273
Closed -$928
COPX icon
616
Global X Copper Miners ETF NEW
COPX
$8.04B
-4,400
Closed -$166K
DAL icon
617
Delta Air Lines
DAL
$60.3B
-1,650
Closed -$78.4K
DELL icon
618
Dell
DELL
$323B
-603
Closed -$32.6K
DLTR icon
619
Dollar Tree
DLTR
$25.2B
-215
Closed -$30.9K
DTE icon
620
DTE Energy
DTE
$29B
-100
Closed -$11K
EQNR icon
621
Equinor
EQNR
$94.8B
-100
Closed -$2.92K
ETR icon
622
Entergy
ETR
$49.9B
-1,004
Closed -$48.9K
EXPE icon
623
Expedia Group
EXPE
$38.9B
-45
Closed -$4.92K
FG icon
624
F&G Annuities & Life
FG
$3.59B
-7
Closed -$173
FRGE
625
DELISTED
Forge Global Holdings
FRGE
-264
Closed -$9.62K

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Loring Wolcott & Coolidge Fiduciary Advisors held 665 positions worth $8.93B, down 4.6% from $9.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2023 filing shows 38 new, 95 increased, 216 reduced and 58 closed positions. Its largest new stake was Veralto: 643,236 shares worth $45.2M. The largest sale was Edwards Lifesciences, an estimated $33.8M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q3 2023 buy was Veralto: 643,236 shares worth $45.2M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Paycom in Q3 2023, an estimated $43.1M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q3 2023 reduction was Edwards Lifesciences, cutting an estimated $33.8M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited iShares 1-3 Year Treasury Bond ETF in Q3 2023, selling an estimated $574K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 46% of its $8.93B portfolio in Q3 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 38 new positions and closed 58 in Q3 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 4.6% quarter-over-quarter to $8.93B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.